October 2, 2019
After their recent collaboration with Grab in August to ensure that medication is delivered within 90 minutes once the teleconsultation session is complete, Singapore-based digital health startup WhiteCoat announced earlier this week that they are partnering with Homage, an on-demand home caregiving services platform to launch a pilot telehealth programme that complements home-based care.
Glen Tullman (second from right) at work with the Livongo team. Photo courtesy Livongo.
September 11, 2019
Livongo isn’t the first company in the digital health space to IPO — at least, depending on how you define “digital health” it isn’t. But even if your definition is broad, Livongo stands out as one of the first companies to go public that’s really focusing on delivering healthcare, not just wellness, using consumer digital technologies.
“People expect us to represent this whole new industry that...
June 19, 2019
Digital chronic condition management company Vida Health has raised $30 million in a strategic Series C round.
Contributors to the round included Florida Blue parent company GuideWell Mutual Holding Corporation, telemedicine giant Teladoc Health and Workday Ventures, the investment arm of enterprise cloud software company Workday, all of which also announced new partnerships or integrations with...
March 20, 2019
Chronic disease management platform Hello Heart will now integrate with LifeScan OneTouch meters as part of its program for diabetes management.
The Redwood City, California-based company started out in hypertension, but has been expanding into diabetes for the past year. OneTouch meters, formerly owned by Johnson & Johnson, are the first of a handful of glucometer brands the company intends...
January 30, 2019
Chronic condition management startup Livongo has acquired MyStrength, a Denver-based digital behavioral health company. The company did not disclose the acquisition price, but Livongo CEO Glen Tullman told MobiHealthNews the figure is in the tens of millions.
“This entry into behavioral was to complete what we call the whole person platform, and to be able to go to someone and say ‘Whatever...
January 2, 2019
Ochsner Health System in New Orleans has been using mobile technology to monitor and manage chronic disease patients since 2015. In that time, the doctors behind the program have learned a lot about how to implement such a system, as well as about how effective it can be.
“We’ve learned a lot,” said Dr. Richard Milani, Ochsner's chief clinical transformation officer and medical director of...
April 11, 2018
Digital chronic disease management company Livongo has raised $105 million in new Series E funding, mostly from existing investors. The company also announced a partnership with nonprofit health insurance company Cambia Health Solutions. General Catalyst and Swedish investment company Kinnevik led the round, with additional participation from existing investors DFJ, Kleiner Perkins Caufield...
February 12, 2018
Correction: A previous version of this article misstated Provata's 2016 revenue.
Merck subsidiary StayWell, which offers a preventative health platform for employers, health plans, and health systems, has acquired Provata Health for an undisclosed sum. Provata Health makes a digital health platform for employee wellness, which includes a chronic disease management program incorporating a...
January 23, 2018
Mount Sinai Health System is trying a new way to get high-risk patients to take their medications: financial incentives. Supported by a grant from Health 2.0 and the New York City Economic Development Corporation, the New York health system has enrolled 12 patients in a pilot with startup Wellth.
“What I’m so impressed with is a lot of companies go out and say ‘We want to make this and this is...
December 27, 2017
Digital health in pharma definitely had a milestone moment in the fourth quarter with the FDA approval of Abilify MyCite, a new, sensor-enabled version of Otsuka’s drug for schizophrenia powered by Proteus Digital Health’s ingestible sensor technology. In addition to that, the quarter saw numerous other moves by pharma companies around clinical trials, chronic disease management, mental health,...